GB2507289B - Composition for parenteral administration, method for producing and use thereof - Google Patents

Composition for parenteral administration, method for producing and use thereof

Info

Publication number
GB2507289B
GB2507289B GB1219111.0A GB201219111A GB2507289B GB 2507289 B GB2507289 B GB 2507289B GB 201219111 A GB201219111 A GB 201219111A GB 2507289 B GB2507289 B GB 2507289B
Authority
GB
United Kingdom
Prior art keywords
producing
composition
parenteral administration
parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1219111.0A
Other versions
GB2507289A (en
GB201219111D0 (en
Inventor
Nikolay Vladimirovich Solovyev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB1219111.0A priority Critical patent/GB2507289B/en
Priority to GB1506139.3A priority patent/GB2523481B/en
Publication of GB201219111D0 publication Critical patent/GB201219111D0/en
Publication of GB2507289A publication Critical patent/GB2507289A/en
Application granted granted Critical
Publication of GB2507289B publication Critical patent/GB2507289B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1219111.0A 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof Active GB2507289B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1219111.0A GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof
GB1506139.3A GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1219111.0A GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof

Publications (3)

Publication Number Publication Date
GB201219111D0 GB201219111D0 (en) 2012-12-05
GB2507289A GB2507289A (en) 2014-04-30
GB2507289B true GB2507289B (en) 2015-09-09

Family

ID=47359403

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1219111.0A Active GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof
GB1506139.3A Active GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1506139.3A Active GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Country Status (1)

Country Link
GB (2) GB2507289B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105866261A (en) * 2016-03-24 2016-08-17 中国药科大学 Metabolism marker group used for diagnosing and differentiating stable angina pectoris and acute coronary syndrome
CN105876137A (en) * 2016-05-13 2016-08-24 菏泽海诺知识产权服务有限公司 Feed for panopea abrupta and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187201A1 (en) * 2001-03-30 2002-12-12 Department Of Biotechnology And Council Of Scientific And Industrial Research Process for the cure and control of diabetes mellitus using natural products from perna viridis
US20030044470A1 (en) * 2001-08-31 2003-03-06 Wani Mohan Ramachandra Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20030148418A1 (en) * 2002-02-06 2003-08-07 Pyntikov Alexander V. Proteolytic fermenter
CN1771997A (en) * 2005-11-07 2006-05-17 上海新药研究开发中心 Trachyostracous mussel extract and its prepn and use
JP2008037766A (en) * 2006-08-02 2008-02-21 Kyosei Seiyaku Kk Angiotensin i converting enzyme inhibitor, and food material and food product having antihypertensive action
JP2009035525A (en) * 2007-08-03 2009-02-19 National Institute Of Advanced Industrial & Technology Melanogenesis inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098106C1 (en) * 1994-02-08 1997-12-10 Центральный научно-исследовательский институт эпидемиологии РФ Method for diagnosing myasthenia
JP2003024008A (en) * 2001-07-19 2003-01-28 Mikimoto Pharmaceut Co Ltd Food
KR100904631B1 (en) * 2007-09-05 2009-07-03 경상대학교산학협력단 Preparation of functional hydrolysates from oyster using transglutaminase
KR101027604B1 (en) * 2009-06-30 2011-04-06 강릉원주대학교산학협력단 A composition comprising the dry powder, polar solvent extract and the insoluble residue of Anthocidaris crassispina as an active ingredient showing liver detoxification and antioxidant activity

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187201A1 (en) * 2001-03-30 2002-12-12 Department Of Biotechnology And Council Of Scientific And Industrial Research Process for the cure and control of diabetes mellitus using natural products from perna viridis
US20030044470A1 (en) * 2001-08-31 2003-03-06 Wani Mohan Ramachandra Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20030148418A1 (en) * 2002-02-06 2003-08-07 Pyntikov Alexander V. Proteolytic fermenter
CN1771997A (en) * 2005-11-07 2006-05-17 上海新药研究开发中心 Trachyostracous mussel extract and its prepn and use
JP2008037766A (en) * 2006-08-02 2008-02-21 Kyosei Seiyaku Kk Angiotensin i converting enzyme inhibitor, and food material and food product having antihypertensive action
JP2009035525A (en) * 2007-08-03 2009-02-19 National Institute Of Advanced Industrial & Technology Melanogenesis inhibitor

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
WPI Abstract Accession No 1985-119074/20 & JP 60058921 *
WPI Abstract Accession No 1997-403203 & CN 1112435A *
WPI Abstract Accession No 2006-729667/76 & CN 1771997 *
WPI Abstract Accession No 2008-D09237/22 & JP 2008037766 *
WPI Abstract Accession No 2009-F14439/17 & JP 2009035525A *
WPI Abstract Accession No 2010-D13002/27 & RU 2384341C1 *
WPI Abstract Accession No 2012-G07383 & KR 20120049042A *

Also Published As

Publication number Publication date
GB2523481A (en) 2015-08-26
GB2523481B (en) 2016-03-16
GB2507289A (en) 2014-04-30
GB201506139D0 (en) 2015-05-27
GB201219111D0 (en) 2012-12-05

Similar Documents

Publication Publication Date Title
HK1200880A1 (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
HK1200879A1 (en) Magnesium-aluminum-zinc alloy, method for the production thereof and use thereof
SG11201406026TA (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
EP2881395A4 (en) Piperazinotrizole compound, preparation method therefor, and use thereof in drug preparation
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
PL2678035T3 (en) Phenalene-1-one derivatives, method for producing same and use thereof
EP2826765A4 (en) Production method for 2,3,3,3-tetra-fluoropropene and 1,1-difluoroethylene
MY156744A (en) Antioxidant, antioxidant composition, and method producing the same
EP2763998A4 (en) Tri-heterocyclic derivatives, preparation process and uses thereof
EP2851378A4 (en) Method for producing oxymethylene copolymer
GB2502390B (en) Novel Ni complex and its derivatives, producing method, and the use thereof as antioxidant
EP2857001A4 (en) Method for producing tablet, and tablet
EP2813495A4 (en) 2-arylbenzofuran-7-formamide compounds, preparation method and use thereof
ZA201501054B (en) Method for producing transition metal compounds, transition metal compounds and use thereof
EP2939999A4 (en) High-purity monoalkenyl-containing glycerin derivative, and method for producing same
EP2905343A4 (en) Method for producing carotenoid-containing composition, and carotenoid-containing composition
EP2821522A4 (en) Method for producing laminate, and laminate
EP2742946A4 (en) Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof
EP2933290A4 (en) Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex
EP2862937A4 (en) Method for producing phospholipid-containing composition, and phospholipid-containing composition
HUE050104T2 (en) 3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof
IL227544B (en) (r)-lauflumide, method for preparing same and therapeutic uses thereof
EP2851359A4 (en) Method for producing 4,4''-dihydroxy-m-terphenyls
HK1212968A1 (en) Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
HK1207261A1 (en) Beverage, and method for producing same

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20171102 AND 20171108